Please follow the link (https://docs.google.com/file/d/0B5CkylMxEtv4TmxtUmxKNE5FR2M/edit ) to review the first rough draft of the TS implementation guide. To
a large extent, this is a synopsis of the ideas presented by the interviewees. As could be expected, there are a lot opinions and the discourse covers a lot of areas, including some that may not be directly related to TS. Our challenge will be to focus the
document to the main points of our outline and do a better job describing the evolutionary “model” of TS that we have been discussing in our recent calls.
Please review and get back to me with comments, either summary or even red-lining if you are so inclined. We will have further discussion on the call on the 29th. As Jennifer summarized on the last call, I will then synthesize feedback
to the writer, they will complete a final round of interviews and revise.
**as a note, I have provide everyone with access the ability to comment on the document.
Jennifer L Williams, MPH, PMP
Please note I have a new office number: 317.274.9239
Health Information Project Manager
Regenstrief Institute, Inc., Center for Biomedical Informatics
410 West 10th Street, Suite 2000
Indianapolis, IN 46202
Confidentiality Notice: The contents of this message and any files transmitted with it may contain
confidential and/or privileged information and are intended solely for the use of the named addressee(s). Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state
laws. Federal regulations and State laws prohibit you from making further disclosure of such information without the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization
for the release of medical or other information is not sufficient for this purpose. If you have received this message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use
of this information by anyone other than the intended recipient is strictly prohibited.